KR101052321B1 - Athlete's foot therapeutic composition - Google Patents

Athlete's foot therapeutic composition Download PDF

Info

Publication number
KR101052321B1
KR101052321B1 KR1020090053823A KR20090053823A KR101052321B1 KR 101052321 B1 KR101052321 B1 KR 101052321B1 KR 1020090053823 A KR1020090053823 A KR 1020090053823A KR 20090053823 A KR20090053823 A KR 20090053823A KR 101052321 B1 KR101052321 B1 KR 101052321B1
Authority
KR
South Korea
Prior art keywords
weight
parts
athlete
foot
fermented
Prior art date
Application number
KR1020090053823A
Other languages
Korean (ko)
Other versions
KR20100135452A (en
Inventor
김진훈
Original Assignee
김진훈
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 김진훈 filed Critical 김진훈
Priority to KR1020090053823A priority Critical patent/KR101052321B1/en
Publication of KR20100135452A publication Critical patent/KR20100135452A/en
Application granted granted Critical
Publication of KR101052321B1 publication Critical patent/KR101052321B1/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/73Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A61K36/739Sanguisorba (burnet)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/80Scrophulariaceae (Figwort family)
    • A61K36/804Rehmannia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/81Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/10Preparation or pretreatment of starting material
    • A61K2236/19Preparation or pretreatment of starting material involving fermentation using yeast, bacteria or both; enzymatic treatment

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

본 발명은 지유, 까마중, 생지황 중 적어도 하나 이상은 발효하여 분쇄한 발효물로 포함되고, 마치현은 태운 잔재로 포함되고, 찔레나무뿌리, 백선피, 용담, 고삼 중 적어도 하나 이상은 액기스로 포함되고, 청미래덩굴잎은 분쇄한 분쇄물로 포함된 무좀 치료 조성물, 특히 손발톱 무좀 치료에 적합한 무좀 치료 조성물을 제공한다. 본 발명에 따른 무좀 치료 조성물은, 장기간 사용하여도 인체에 안전성이 높은 것으로 검증된 한약 또는 식물 재료를 사용하고, 무좀 질환 부위에 직접 도포하여 치료함으로써 부작용을 최소화할 수 있으며, 특히 손발톱 무좀 치료에 탁월한 효능을 갖는다. The present invention includes at least one or more of fat milk, black yam, raw sulfur, fermented and pulverized fermented product, March is included as a burned remnant, at least one of brier roots, ringworm skin, gentian, red ginseng is included as an extract , Blue vine leaf provides a athlete's foot treatment composition, in particular, the athlete's foot athlete's foot treatment composition contained in the pulverized powder. Athlete's foot treatment composition according to the present invention can minimize side effects by using a herbal or plant material that has been proven to be safe for humans even after long-term use, and directly applied to the athlete's foot disease site, especially in the treatment of nail athlete's foot Has excellent efficacy

무좀, 손발톱 무좀, 조갑백선 Athlete's foot, nail athlete's foot, ringworm

Description

무좀 치료 조성물{Pharmaceutical composition for application to tinea pedis}Athlete's foot therapeutic composition {Pharmaceutical composition for application to tinea pedis}

본 발명은 무좀 치료 조성물, 특히 손발톱 무좀 치료 조성물에 관한 것이다.The present invention relates to athlete's foot therapeutic compositions, in particular to nail athlete's foot therapeutic compositions.

손, 발 등의 무좀(tinea pedis)과 손발톱의 진균 감염(조갑백선; onychomycosis), 일명 손발톱 무좀은 세계적으로 널리 퍼져있는 질환이다. 자가 치유되지 않는 이러한 만성 병리학적 존재는 고도로 개발된 산업화된 국가에서 특히 중요성이 증가되고 있다. 손발톱 무좀은 40%까지의 비율을 포함하는, 손발톱의 가장 흔한 질환을 구성한다. 손발톱 무좀의 유행은 당해 분야에서 2.8% 내지 8.4%라고 공식적으로 발표된다. 손발톱의 사상균병(mycosis)은 모든 피부진균증의 약 30%를 차지한다. 역학적 연구를 통해 무좀(Tinea pedis)이 있는 환자의 20% 내지 30%가 손발톱 무좀도 앓는 것으로 밝혀졌다.Athlete's foot (tinea pedis) and nail fungal infections (onychomycosis), also known as nail athlete's foot, are a widespread disease worldwide. This chronic pathological presence, which is not self-healing, is of increasing importance, especially in highly developed industrialized countries. Nail athlete's foot constitutes the most common disease of nails, including up to 40% of proportions. The prevalence of nail athlete's foot is officially announced in the art to be 2.8% to 8.4%. Mycosis of nails accounts for about 30% of all skin fungal diseases. Epidemiologic studies have shown that 20% to 30% of patients with Tinea pedis also have nail athlete's foot.

다수의 환자들은 특히 명백히 드러나는 손톱에 조갑백선이 있는 경우, 이들의 사회적 교류에서 위축을 느낀다.Many patients feel atrophy in their social interactions, especially if they have anchovy tinnitus on their apparent nails.

또한, 병리학적 사건은 감촉성(tactility), 운동성 및 수동 능력(manual ability)이 제한받게 된다. 치료의 필요성은 조갑백선이 감염의 근원으로서 손발톱으로부터 피부로의 질환 확산의 원인이라는 사실로부터도 도출된다. 또한, 이는 끊임없이 증가하는 인구에게서 감염의 위험을 나타낸다.In addition, pathological events are limited in tactility, motility and manual ability. The need for treatment also stems from the fact that ringworm is the cause of the spread of the disease from the nails to the skin as the source of infection. It also represents a risk of infection in a constantly growing population.

1990년대 초반부터, 조갑백선을 치료하기 위한 다수의 신규 치료방법이 개발되어 왔다. 이에 한편으로는 신규한 전신성 활성 항진균제; 예를 들어 이트라코나졸[참조문헌: 미국 특허 제4,267,179호]; (E)-N-(6,6-디메틸-2-헵텐-4-이닐)-N-메틸-1-나프탈렌메탄아민[터비나핀(terbinafine)으로도 명명]; α-(2,4-디플루오로페닐)-α-(1H-1,2,4-트리아졸-1-일메틸)-1H-1,2,4-트리아졸-1-에탄올[플루코나졸(fluconazole)로도 명명] 뿐만 아니라, 조갑백선 치료를 보다 잘되게 하는 국부적으로 사용되는 래커 제제가 있다.Since the early 1990s, a number of new treatments have been developed for treating ringworm. On the one hand, novel systemic active antifungal agents; For example itraconazole (US Pat. No. 4,267,179); (E) -N- (6,6-dimethyl-2-hepten-4-ynyl) -N-methyl-1-naphthalenemethanamine (also named terbinafine); α- (2,4-difluorophenyl) -α- (1H-1,2,4-triazol-1-ylmethyl) -1H-1,2,4-triazole-1-ethanol [fluconazole ( As well as fluconazole, there are also locally used lacquer preparations that make treatment of ringworm better.

전신 치료는 활성 성분이 혈액 순환을 통해 감염된 부위로 도달하게 되어있기 때문에, 어떤 상황에서는 생명을 위협할 수도 있는, 약제의 원치 않는 심각한 부작용이 가끔 일어날 수 있다. 기타 약제를 사용한 부작용 및 감염은, 특히 사망률 높은 다수의 노령 환자에게서 피할 수 없는 것이다. 전신성 항진균제는, 예를 들어 치료될 수 있는 병원체의 범주에서의 차이, 몇몇 경우에는 신뢰할 수 없는 흡수의 차이와 같은, 원치 않는 기타 부수적인 효과를 부가적으로 갖는다.Systemic treatment requires active ingredients to reach the infected site through the blood circulation, so in some situations unwanted and serious side effects of the drug can occur, which can sometimes be life-threatening. Side effects and infections with other agents are inevitable, especially in many elderly patients with high mortality. Systemic antifungal agents additionally have other undesirable side effects, such as differences in the range of pathogens that can be treated, in some cases differences in unreliable absorption.

조갑백선 치료시 국부 및 전신성 항진균제를 사용한 복합 치료의 단점은, 당해 치료법으로 치료받는 환자들 조차 이와 관련된 모든 부작용을 갖는 시스템에 대 해 여전히 중압감을 갖는다는 것이다. 또 다른 중요한 단점은, 손발톱에 도달하는 전신성 항진균제의 양이 적다는 것이다. 또한 현재까지는, 손발톱에 예를 들어 이트라코나졸과 같은 전신성 항진균제를 치료학적 유효 농도로 국부 적용하는, 매우 복잡하고 발본적인 방법만이 가능했다.The disadvantage of combined treatment with topical and systemic antifungal agents in the treatment of ringworm is that even patients treated with the therapy still have a heavy pressure on the system with all the associated side effects. Another important drawback is the low amount of systemic antifungal agents that reach the nails. Also to date, only very complex and fundamental methods have been possible, whereby topically applying systemic antifungal agents, such as itraconazole, to the nail in therapeutically effective concentrations.

따라서 본 발명의 목적은 상기의 문제점을 고려하여 장기간 사용하여도 인체에 안전성이 높은 재료를 사용하고, 무좀 질환 부위, 특히 손발톱 무좀 질환 부위에 직접 도포하여 치료함으로써 부작용을 최소화할 수 있는 무좀 치료 조성물을 제공하는 것이다.Accordingly, an object of the present invention is to use a high-safety material for long-term use in consideration of the above-mentioned problems, and athlete's foot treatment composition that can minimize the side effects by applying directly to the athlete's foot disease site, especially nail foot disease site treatment To provide.

본 발명의 목적을 달성하기 위한 수단으로서, As a means for achieving the object of the present invention,

본 발명은, 지유, 까마중, 생지황을 발효하여 분쇄한 발효물로서, 지유 발효물 40-80 중량부, 까마중 발효물 10~40 중량부, 생지황 발효물 10~40 중량부; 마치현을 태운 잔재 10~30 중량부; 도꼬마리 3~10 중량부, 찔레나무뿌리 3~10 중량부, 백선피 3~10 중량부, 용담 3~10 중량부, 고삼 3~10 중량부를 물과 함께 용기에 넣고 다려 추출한 액기스 3~50 중량부; 및 청미래덩굴잎을 분쇄한 분쇄물 10~30 중량부;를 포함하여 이루어진 무좀 치료 조성물을 제공한다.The present invention is a fermentation product obtained by fermenting ground sulfur, fermented raw milk, brown fat, 40-80 parts by weight of fermented milk fat, 10-40 parts by weight of fermented soybean paste, and 10-40 parts by weight of raw sulfur fermented product; 10-30 parts by weight of residue burned Machi; 3 ~ 10 parts by weight of Dokomari, 3 ~ 10 parts by weight of brier roots, 3 ~ 10 parts by weight of ringworm skin, 3 ~ 10 parts by weight of gentian, and 3 ~ 10 parts by weight of red ginseng in a container with water part; It provides a athlete's foot treatment composition comprising a;

또한, 지유, 까마중, 생지황 중 적어도 하나 이상을 발효하여 분쇄한 발효물 10~160 중량부; 마치현을 태운 잔재 10~30 중량부; 도꼬마리, 찔레나무뿌리, 백선피, 용담, 고삼 중 적어도 하나 이상을 물과 함께 용기에 넣고 다려 추출한 액기스 3~50 중량부; 및 청미래덩굴잎을 분쇄한 분쇄물 10~30 중량부;를 포함하여 이루어 진 무좀 치료 조성물을 제공한다.In addition, 10 ~ 160 parts by weight of the fermented milled by fermenting at least one or more of fat milk, black horse, raw sulfur; 10-30 parts by weight of residue burned Machi; 3 to 50 parts by weight of extract extracted by putting at least one or more of dokomari, brier roots, ringworm skin, gentian, red ginseng with water; It provides a athlete's foot treatment composition comprising a;

또한, 지유, 까마중, 생지황 중 적어도 하나 이상을 발효하여 분쇄한 발효물; 마치현을 태운 잔재; 도꼬마리, 찔레나무뿌리, 백선피, 용담, 고삼 중 적어도 하나 이상을 물과 함께 용기에 넣고 다려 추출한 액기스; 및 청미래덩굴잎을 분쇄한 분쇄물;을 포함하여 이루어진 무좀 치료 조성물을 제공한다.In addition, fermented products obtained by fermenting at least one or more of fat milk, black roe, raw sulfur; Remnants burning Machi Prefecture; An extract obtained by putting iron at least one or more of oxtail, brier root, ringworm skin, gentian and red ginseng into a container with water and extracting it; And pulverized crushed blue rice vine leaves; provides a athlete's foot treatment composition comprising a.

또한, 지유 40 중량부, 까마중 20 중량부, 마치현 10 중량부, 생지황 10 중량부를 발효하여 분쇄한 발효물을 포함하여 이루어진 무좀 치료 조성물을 제공한다.In addition, 40 parts by weight of fat milk, 20 parts by weight of the horseradish, 10 parts by weight guchi, 10 parts by weight of raw sulfur to provide a athlete's foot therapeutic composition comprising a fermented and ground.

본 발명의 지유, 까마중, 생지황 중 적어도 하나 이상은 발효하여 분쇄한 발효물로 포함되고, 마치현은 태운 잔재로 포함되고, 찔레나무뿌리, 백선피, 용담, 고삼 중 적어도 하나 이상은 액기스로 포함되고, 청미래덩굴잎은 분쇄한 분쇄물로 포함된 무좀 치료 조성물은 장기간 사용하여도 인체에 안전성이 높은 것으로 검증된 한약 또는 식물 재료를 사용하고, 무좀 질환 부위, 특히 손발톱 무좀 질환 부위에 직접 도포하여 치료함으로써 부작용을 최소화할 수 있으며, 손발톱 무좀 치료에 탁월한 효능을 갖는 것을 볼 수 있다. At least one or more of the fat, yam, raw sulfur of the present invention is included as a fermented and crushed fermentation, March prefecture is included as a burned residue, at least one of brier roots, ringworm skin, gentian, red ginseng is included as an extract , Athlete's foot treatment composition, which contains crushed crushed leaves, uses Chinese medicine or plant material that has been proven to be safe for humans even after long-term use, and is applied directly to athlete's foot disease areas, especially nail foot disease areas. By minimizing the side effects, it can be seen to have excellent efficacy in treating nail athlete's foot.

이하, 실시예를 통하여 본 발명을 보다 상세하게 설명한다. 하기의 설명은 본 발명의 구체적 일례에 대한 것이므로, 비록 단정적, 한정적 표현이 있더라도 특허청구범위로부터 정해지는 권리범위를 제한하는 것은 아니다.Hereinafter, the present invention will be described in more detail with reference to Examples. The following descriptions are for specific examples of the present invention, but are not intended to limit the scope of the rights set forth in the claims, even if there is an assertive or limited expression.

본 발명의 일실시예에 따른 무좀 치료 조성물은 지유, 까마중, 생지황 중 적어도 하나 이상을 발효하여 분쇄한 발효물; 마치현을 태운 잔재; 도꼬마리, 찔레나무뿌리, 백선피, 용담, 고삼 중 적어도 하나 이상을 물과 함께 용기에 넣고 다려 추출한 액기스; 및 청미래덩굴잎을 분쇄한 분쇄물;을 포함하여 이루어진 것을 특징으로 한다. Athlete's foot treatment composition according to an embodiment of the present invention is fermented by grinding at least one fermentation of at least one of fat milk, black yam, raw sulfur; Remnants burning Machi Prefecture; An extract obtained by putting iron at least one or more of oxtail, brier root, ringworm skin, gentian and red ginseng into a container with water and extracting it; And a pulverized product of crushed blue rice vine leaves.

본 발명에서는 무좀 치료, 특히 손발톱 무좀 치료를 위하여 최적의 조합물을 발명하였으며, 더 나아가 효과를 더욱 좋게 하기 위하여 조성물 구성시 그 형태가 발효물, 잔재, 액기스, 분쇄물의 조합인 것을 특징으로 한다.In the present invention, the optimum combination for the treatment of athlete's foot, especially nail athlete's foot, has been invented, and in order to further improve the effect, the composition is characterized in that the combination of fermented product, residue, extract and ground product.

즉, 지유, 까마중, 생지황은 발효하여 분쇄한 발효물로 포함되는 것이 바람직하며, 마치현은 태운 잔재로 포함되는 것이 좋고, 도꼬마리, 찔레나무뿌리, 백선피, 용담, 고삼은 물과 함께 용기에 넣고 다려 추출한 액기스로 포함되는 것이 좋고, 청미래덩굴잎은 분쇄한 분쇄물로 포함되는 것이 보다 바람직하다. 이중 마치현은 필요에 따라 발효물로 포함될 수도 있다.In other words, it is preferable to include the fat milk, yam, and raw sulfur in fermented and crushed fermented products. It is preferable that it is contained in the extract extracted iron, and it is more preferable that blue vine leaves are contained in the pulverized powder. Double port may also be included as fermentation if necessary.

본 발명에서 명명하는 무좀에는 손, 발 등의 무좀과, 손발톱의 무좀을 모두 포함하는 넓은 의이미다.Athlete's foot, which is named in the present invention, is a broad meaning that includes both athlete's foot, such as hands and feet, and athlete's foot.

지유(地楡, Sanguisorbae Radix)는 오이풀 및 동속근연식물의 뿌리로 한방에서는 낭혈지혈, 해독렴창, 치면혈의 효능이 있어 치출혈, 혈리, 불루, 수화탕상, 옹종창독에 사용되어왔다.Jigui (地 楡, Sanguisorbae Radix) is the root of cucumber and coriander root plants. It has the effect of cystic hemostasis, detoxification and dental floss in oriental medicine, and has been used for hemorrhage, hemostasis, blue, hydration, and carbuncle.

까마중은 가지과의 일년초로서 우리나라 전국 각처의 원야지(原野地), 대개 밭이나 길가, 초원(草原)에 흔히 자생한다. 저지대의 길가나 밭 주의에 자라며 높이 20~90 ㎝이고, 가지가 옆으로 많이 퍼지며 원줄기에 능선이 약간 나타난다. 한약명으로는 용규(龍葵, 全草를 말린 것)라고 하는데, 전초(全草)와 열매는 옛부터 민간에서 종기나 악성부스럼을 치료하는 약재로 흔히 써 왔다. 북한에서 발행된 동의학사전과 우리나라 중국의 옛 문헌에는 "맛이 쓰고, 독을 풀며, 열을 내리고, 혈을 잘 돌게 한다. 소변이 잘 나오게 하며, 복수가 찰 때 염증을 없애고, 종양을 억제하는 작용이 있어 항암치료에 쓰인다" 고 밝히고 있다. Cama is a year-old herbaceous plant, common to native fields in all parts of Korea, fields, roadsides, and grasslands. It grows on the roadside or field of lowlands and has a height of 20 ~ 90 ㎝. Branches spread a lot and some ridges appear on the main stem. The name of the Chinese medicine is Yonggyu (Dongryu, dried grass), the outpost (全 草) and fruit has long been used as a medicine to treat boils and malignant swelling in the private sector. The book of synonym published in North Korea and the old literature of China in Korea say, "It tastes bitter, detoxifies, lowers heat, and circulates blood well. It helps to urinate, removes inflammation and suppresses tumors. It is used for chemotherapy. "

우리나라에 자생하는 까마중은 그 학명이 대부분의 식물도감에서는 Solanaceae(가지과)의 Solanum nigrumLinnaeus(미국명 : Black Nightshade)로 표기되어 있으나, 조사에 의하면 최근 분류학상 Solanum ptycanthum(미국명 : Eastern Black Nightshade)으로 분류되어 있다. 두 종은 거의 비슷한 형태를 가지나, 가장 큰 차이는 Solanum nigrum Linnaeus의 열매 내에는 종자(sclerotic granules)를 가지고 있지 않지만, Solanum ptycanthum은 열매의 내부에는 열매 당 40∼50개 정도의 종자를 가지고 있다. Among the crows growing in Korea, the scientific name is indicated as Solanum nigrumLinnaeus (US name: Black Nightshade) of Solanaceae in most plants, but according to the recent taxonomy Solanum ptycanthum (US name: Eastern Black Nightshade) It is classified. The two species have almost similar morphology, but the biggest difference is that there are no sclerotic granules in the fruit of Solanum nigrum Linnaeus, but Solanum ptycanthum has about 40-50 seeds per fruit inside the fruit.

생지황(Rehmannia glutinosa Libschitz var. purpurea Makino)은 현삼과에 속하는 다년생 초본식물의 신선한 뿌리를 약재로 쓰는데, 이것을 지황이라고 한다. 신선한 근경을 생지황 또는 선지황, 말린 것을 건지황, 생지황을 황주(黃酒)에 넣고 찌고 햇볕에 말린 것을 9번 거듭한 것을 숙지황이라고도 한다.Rehmannia glutinosa Libschitz var.purpurea Makino uses fresh roots of perennial herbaceous plants belonging to the family Ginsengaceae as a medicine. Fresh root roots of fresh or seonjihwang, dried dried kohwanghwang, raw sulfur added to Hwangju (黃酒) steamed and sun dried 9 times repeated is also known as sujijihwang.

마치현은 쇠비름(Portulaca oleracesa L.)의 전초이고, 주요성분이 Alanine, Aspartic acid, Oleic acid, Phorbic acid, 비타민 C, 도파민(Dopamine), 사포닌(Saponine), 타닌(Tannin) 등이고, 피부진균, 대장균, 이질균, 황색포도상구균 등의 억제작용, 장관의 활발한 연동작용, 이뇨작용이 있고, 상처 치유효과가 우수하여 피부 질환에 폭넓게 사용되고, 피부 건조 예방과 항염작용, 피부자극과 알레르기 반응 진정효과가 있다.Portulaca is an outpost of purslane (Portulaca oleracesa L.), and its main ingredients are Alanine, Aspartic acid, Oleic acid, Phorbic acid, Vitamin C, Dopamine, Saponine, Tannin, etc. It is used widely for skin diseases because it has the inhibitory effect of dysentery, Staphylococcus aureus, active peristalsis of the intestine, diuretic effect, and excellent wound healing effect. .

도꼬마리(Xanthium strumarium L.)는 국화과(Compositae)에 속하는 것으로서, 전체에 거센 털이 나 있으며 줄기는 곧게 서고, 키는 1.5 m 정도이다. 꽃은 8-9월경에 황갈색을 띈 머리 꽃이 줄기 끝에서 핀다. 열매는 대추씨와 비슷하고 과피 부분에 갈고리 모양의 억센 털이 나 있으며 들이나 길가에서 주로 자라는 한해살이풀로 한국을 포함한 동북아시아 및 유럽 등지에 폭넓게 분포·자생하는 것으로 알려져 있다. 도꼬마리에 관한 연구는 중국산 도꼬마리(Xanthium sibiricumPatr. ex Widd)가 시초로서 열매의 씨(창이자)가 해열, 발한, 진통, 산풍, 거습, 신경통 및 악성 종양 등에 효과가 있는 것으로 알려져 있다. Xanthium strumarium L. belongs to the family Asteraceae (Compositae), with hairs all over, its stem is straight, and its length is about 1.5 m. Flowers bloom from August to September at the tip of stem with yellowish-brown head flowers. The fruit is similar to jujube seed, and has thick hairs in the shape of pericarp. It is an annual herb that grows mainly in fields or roadsides, and is widely distributed and grown in Northeast Asia and Europe including Korea. Studies on the larvae are known to be the origin of the Chinese spearfish (Xanthium sibiricum Patr. Ex Widd), which is effective for fever, sweating, analgesic, mountain breeze, roughness, neuralgia and malignant tumors.

찔레나무(Rosa multiflora )는 장미과의 낙엽관목으로 전국의 산기슭이나 하천유역에 광범위하게 분포하는 식물이다. 한방에서는 열매를 영실이라는 약제로 사용하는데, 불면증, 건망증, 성기능 감퇴, 부종에 효과가 있다고 알려져 있으며 이뇨제로도 사용된다. 본 발명의 일실시예에서는 찔레나무의 뿌리를 사용한다.Rosa multiflora is a deciduous shrub of the family Rosaceae and is widely distributed in foothills and river basins throughout the country. In oriental medicine, fruit is used as a drug called Youngsil, and it is known to be effective in insomnia, forgetfulness, decreased sexual function, and edema. It is also used as a diuretic. In one embodiment of the present invention, the root of the brier is used.

백선피(Dictamnus dsycarpus Turez)는 운향과의 여러해살이풀로 50 ~ 100cm정도 자란다. 각지의 산기슭 낮은 언덕에서 자라는 데 여름에 흰색 또는 분홍색 꽃이 핀다. 이 식물에서 양냄새(선)가 난다고 하여 백선, 백양선이라 한다. 가을에 뿌리를 캐서 물로 씻고 껍질을 벗겨 말린다. 성분으로는 뿌리에 알칼로이드가 0.13% 있고, 뿌리껍질에는 0.02 ~ 0.03%의 딕탐닌(딕타민), 또한 스킴미아닌, 트리코넬린, 콜린, 딕탐노락톤, 프락시넬론, 딕탐놀리드, 오바쿠논, 사포닌, 캄페스테롤, 시토스테롤, 정유 등이 있다. 한의에서 사지불안 중풍에 쓰이는 중요한 약재로 알려져 있고, 기생충약으로 쓰이며 간헐열, 두통, 류마티스, 척수신경근염, 뇌막염, 월경장애, 황달 등에 열내림약, 진통약, 거풍약, 진경약, 진정약, 이뇨약으로 쓰인다. Dictamnus dsycarpus Turez is a perennial herb that grows about 50-100 cm. It grows in the low hills of various parts of the country, with white or pink flowers in summer. Sheep smelling from this plant is known as ringworm and baekyangseon. In the autumn, digging roots, washing with water, peeled and dried. Ingredients include 0.13% alkaloids in the roots, 0.02% to 0.03% in the root bark, methhamine, triconelline, choline, dictamnolactone, proxinelon, dictamnolide, and obaku. Paddy, saponin, camphorsterol, cytosterol, essential oils and the like. It is known as an important medicine used for quadriplegic anxiety in oriental medicine, and it is used as a parasitic medicine, and it is a fever lowering medicine, analgesic medicine, acupuncture medicine, analgesic medicine, sedative medicine, etc. Used as a diuretic.

용담(Gentianae Scabrae Radix)은 대고대한(大苦大寒)하여 청열조습(淸熱燥濕) 작용이 뛰어나며 특히 하초(下焦)의 습열(濕熱)을 청(淸) 하는데 뛰어난 것으 로 알려져 있다. 침강(沈降)하는 성질이 있어 간담경(肝膽經)의 실화(實火)를 사(瀉)하는 작용이 좋으며, 성분(成分)으로는 겐티오피크린(Gentiopicrin), 슈베르티아마린(Swertiamarin),겐티아닌(Gentianine), 겐티신(Gentisin), 겐티아노즈(Gentianose)등이 알려져 있다. Gentianae Scabrae Radix is large and is known for its excellent heat and humidity control. It is especially known for its excellent moist heat. It has the property of sedimentation, so it is good to kill the fire loss of hepatobiliary bile. Its ingredients include geniopicrin and Swertiamarin. Gentianine, Gentisin, Gentianose and the like are known.

고삼(Sophora angustifolia SIEB. et Zucc)은 다년생 초본으로 다 자라면 높이 1m에 달하는 콩과의 다년생초본이다. 잎모양이 회화나무(괴화)와 비슷하여 지괴, 수괴, 야괴라는 별명이 있다. 가을에 뿌리를 캐어 씻어 말리며, 맛이 쓰지만 인삼과 같은 효과가 있다하여 고삼이라 한다. 고삼의 성분으로는 식물전체에 알칼로이드가 있다. 뿌리의 총 알칼로이드는 1.1%이며, 알칼로이드의 성분은 마트린(소포카르피딘), 옥시마트린, 소포라놀, 아나기린, 메틸시티진, 바브티플린, 소포카르핀, 알로마트린 등이 있다. 이 밖에 약 13%의 당분이 있으며, 뿌리에서 플라보놀화합물인 이소안히드로이카리딘, 노르안히드로이카리딘 등이 분리되었다.Ginseng (Sophora angustifolia SIEB. Et Zucc) is a perennial herb, a perennial herb that grows to 1m in height when grown. Its leaf shape is similar to the painting tree, which is nicknamed worms, lumps and wild beasts. The roots are washed and dried in autumn, and the taste is bitter, but it is called ginseng because it has the same effect as ginseng. As a component of red ginseng, there are alkaloids throughout the plant. The total alkaloid of the root is 1.1%, and the components of the alkaloid include matrin (sofocarpidine), oxymatrine, sophoranol, anagirin, methylcytizin, barbifflin, sofocarpine, and allomatine. In addition, there is about 13% sugar, and the flavonol compounds isoanhydroicaridine, noranhydroicaridine, etc. were separated from the root.

청미래덩굴은 명감나무라고도 하며, 동의학사전에 기재된 약효를 보면, 맛은 슴슴하고 성질은 평하다. 위경, 간경에 작용한다. 열을 내리고 습을 없애며 독을 푼다. 뼈마디가 아픈 데, 매독, 연주창, 헌 데, 악창, 수은 중독을 푼다. 하루 10~15g을 달인 약, 약술, 가루약, 알약 형태로 먹는다.라고 기재되어 있다. 열매는 식용하며 어린 순은 나물로 먹는다. 뿌리를 이뇨 ·해독 ·거풍 등의 효능이 있어 관절염 ·요통 ·종기 등에 사용한다. 또한, 동의학사전에 기재된 내용에는 "본초 강목에 요즈음 여자를 좋아하는 사람이 많아 매독 같은 성병이 많이 유행하고 있다. 약을 써서 고친 뒤에 자주 재발하곤 하므로 오래 고생을 하게 되는데 이럴 때 청미래덩굴 뿌리를 쓰면 효과가 좋다" 라고 적혀있고, 한방에서는 매독뿐 아니라 임질, 태독, 악창 등에 두루 효과가 있다고 알려진 약초이다.Cheongmirae vine is also known as Myeonggam wood, and if you look at the medicinal effects described in the synonym dictionary, the taste is hearty and the properties are flat. It acts on the stomach and liver. Lowers heat, decays, and poisons. Bones are sore, syphilis, playing, boil, bad, mercury poisoning. Eat 10-15g per day in the form of decoctions, medicines, powdered pills, pills. Fruits are edible and young sprouts are eaten as herbs. Roots are effective for diuresis, detoxification, gusts, etc. Used for arthritis, back pain, and boils. In addition, the contents of the synonym dictionary stated, "Since there are many people who prefer women in herbaceous trees these days, many sexually transmitted diseases such as syphilis have become popular. Because they often recur after using medicine, they suffer a long time. The effect is good. "

본 발명의 보다 바람직한 실시예로서, 무좀 치료 조성물은 지유, 까마중, 생지황 중 적어도 하나 이상을 발효하여 분쇄한 발효물 10~160 중량부, 마치현을 태운 잔재 10~30 중량부, 도꼬마리, 찔레나무뿌리, 백선피, 용담, 고삼 중 적어도 하나 이상을 물과 함께 용기에 넣고 다려 추출한 액기스 3~50 중량부, 및 청미래덩굴잎을 분쇄한 분쇄물 10~30 중량부를 포함하여 이루어지는 것이 좋다. 본 발명에서 사용하는 중량부는 각 성분의 중량비를 의미하는 것이다. As a more preferred embodiment of the present invention, the athlete's foot treatment composition is 10 ~ 160 parts by weight of fermented crushed by fermenting at least one or more of fatty milk, black yam, raw sulfur, 10 ~ 30 parts by weight of the residue burned machi, dokmari, brier roots At least one or more of ringworm, gentian, and red ginseng are put in a container with water, and 3 to 50 parts by weight of extracted extract, and 10 to 30 parts by weight of pulverized crushed blue vine leaves. The weight part used by this invention means the weight ratio of each component.

더욱 바람직하기로는 무좀 치료 조성물은 지유, 까마중, 생지황을 발효하여 분쇄한 발효물로서, 지유 발효물 40-80 중량부, 까마중 발효물 10~40 중량부, 생지황 발효물 10~40 중량부, 마치현을 태운 잔재 10~30 중량부, 도꼬마리 3~10 중량부, 찔레나무뿌리 3~10 중량부, 백선피 3~10 중량부, 용담 3~10 중량부, 고삼 3~10 중량부를 물과 함께 용기에 넣고 다려 추출한 액기스 3~50 중량부, 및 청미래덩굴잎을 분쇄한 분쇄물 10~30 중량부를 포함하여 이루어진 것이 좋다. More preferably, the athlete's foot therapeutic composition is a fermented product obtained by fermenting fat milk, yam, and raw sulfur, 40-80 parts by weight of fermented milk, 10-40 parts by weight of fermented milk, 10-40 parts by weight of fermented sulfur, Machi 10-30 parts by weight of residues burned, 3-10 parts by weight of Dokomari, 3-10 parts by weight of brier roots, 3-10 parts by weight of ringworm skin, 3-10 parts by weight of gentian, 3-10 parts by weight of red ginseng 3 to 50 parts by weight of the extract extracted and put into the iron, and 10-30 parts by weight of the pulverized ground crushed blue vine leaf is good.

또 다른 일실시예로서, 무좀 치료 조성물은 지유 40 중량부, 까마중 20 중량부, 마치현 10 중량부, 생지황 10 중량부를 발효하여 분쇄한 발효물을 포함하여 이 루어질 수 있다. 이외에도 상기의 잔재, 액기스, 분쇄물을 더 포함할 수 있다.In another embodiment, the athlete's foot therapeutic composition may be made of 40 parts by weight of fat milk, 20 parts by weight of yam, 10 parts by weight of gut string, 10 parts by weight of fermented soybeans, fermented and ground. In addition to the residue, the extract, it may further comprise a pulverized product.

상기의 무좀 치료 조성물은 통상의 방법에 따라 젤, 로션, 크림, 연고 등의 외용제로 사용되는 것이 좋다. 일반적으로 외용제에 첨가되는 공지의 성분들이 제한되지 않고 사용될 수 있으며 약물 수송을 돕는 다양한 성분들이 추가될 수 있다. 일례로는 용제 겸 담체로서 글리세린, 계면활성제를 들 수 있다. 또한, 본 발명의 효과를 손상시키지 않는 범위에서 각종 공지의 첨가제, 예를 들어, 산화방지제, 향료, 착색제, 보존제등을 첨가하여 제조할 수 있다. 상기와 같은 첨가제의 예로는 부틸히드록시아니솔, 디부틸히드록시톨루엔와 같은 산화방지제; 파라옥시 안식향산 에스테르 또는 디히드로 아세트산과 같은보존제; 디나트륨에데테이트 또는 테트라나트륨 에데테이트와 같은 킬레이트화제, 정제수 등을 예시 할 수 있다.The athlete's foot treatment composition may be used as an external preparation such as gel, lotion, cream, ointment according to a conventional method. In general, known ingredients added to external preparations can be used without limitation, and various ingredients to aid drug transport can be added. As an example, glycerin and surfactant are mentioned as a solvent and a support | carrier. Moreover, it can manufacture by adding various well-known additives, for example, antioxidant, a fragrance | flavor, a coloring agent, a preservative, etc. in the range which does not impair the effect of this invention. Examples of such additives include antioxidants such as butylhydroxyanisole and dibutylhydroxytoluene; Preservatives such as paraoxy benzoic acid ester or dihydro acetic acid; Chelating agents, such as disodium edetate or tetrasodium edetate, purified water, etc. can be illustrated.

<실시예 - 무좀 치료 조성물의 제조>Example-Preparation of Athlete's Foot Treatment Composition

1. 지유,까마중,생지황을 각각 토기에 설탕 10% 농도의 물에 잠길 정도로 넣은 다음 30일-60일간 발효시킨 후 건져서 곱게 분쇄하여 지유 40-80g, 까마중 10-40g, 생지황 10-30g을 준비하였다.1. Put the milk, yam, and raw sulfur in the earthenware soaked in water of 10% of sugar in the earthenware, ferment for 30 days to 60 days, and then crush it finely. It was.

2. 건조한 마치현 500g을 태운 다음 밀페용기에 20-30일 담아두었다가 위의 재는 버리고 10-30g을 준비하였다.2. After drying 500g of dried gut string, put it in a sealed container for 20-30 days, discarded the ash and prepared 10-30g.

3. 도꼬마리 3-10g, 찔레나무뿌리 3-10g, 백선피 3-10g, 용담 3-10g, 고삼3-10g을 용기에 넣고 물 1리터 넣은 다음 40분에서 60분간 다린 후 추출하여 얻어진 액기스 50g을 준비하였다.3. Put 3-10g of Docomari, 3-10g Brier Root, 3-10g White Pine, 3-10g Gentian, and 3-10g of Red Ginseng into a container, add 1 liter of water, and steam for 40 to 60 minutes, and then extract 50g. Was prepared.

4. 청미래덩굴잎 10-30g을 분쇄하여 준비하였다.4. 10-30 g of blue vine leaves were prepared by grinding.

5. 위의 내용물들을 글리세린3-15g과 혼합하여 무좀 치료 조성물을 제조하였다.5. The above contents were mixed with 3-15 g of glycerin to prepare athlete's foot therapeutic composition.

<임상예 - 무좀 치료 조성물의 효능 테스트>Clinical Example-Test of efficacy of athlete's foot treatment composition

<임상예 1><Clinical example 1>

(1) 환자 : 45세 여성(1) Patients: 45 years old female

(2) 증상 : 도 1a와 같이 손톱과 발톱에 무좀이 발생함(2) Symptoms: Athlete's foot occurs on the nails and toenails as shown in Figure 1a

(3) 치료 : 실시예에서 얻어진 손발톱 무좀 치료 조성물을 매일 3회 환부에 도포함.(3) Treatment: Incorporate the nail athlete's foot athlete's foot therapeutic composition obtained in the Example into the affected area three times daily.

(4) 경과 : 도 2a와 같이 35일 치료로 완치됨.(4) Progress: cured with 35 days of treatment as in FIG. 2A.

<임상예 2><Clinical example 2>

(1) 환자 : 48세 남성(1) Patients: 48 year old male

(2) 증상 : 도 2a와 같이 엄지 손톱에 무좀이 발생함(2) Symptoms: Athlete's foot occurs on the thumb as shown in Figure 2a

(3) 치료 : 실시예에서 얻어진 손발톱 무좀 치료 조성물을 매일 1회 환부에 도포함.(3) Treatment: The nail athlete's foot treating composition obtained in the Example is included in the affected area once daily.

(4) 경과 : 도 2b와 같이 45일 치료로 완치됨.(4) progress: cured with 45 days treatment as in FIG. 2b.

<임상예 3><Clinical example 3>

(1) 환자 : 32세 남성(1) Patients: Male 32 years old

(2) 증상 : 도 3a와 같이 모든 손톱에 무좀이 발생함(2) Symptoms: Athlete's foot occurs on all nails as shown in Figure 3a

(3) 치료 : 실시예에서 얻어진 무좀 치료 조성물을 매일 3회 환부에 도포함.(3) Treatment: The athlete's foot therapeutic composition obtained in Example is included in the affected area three times daily.

(4) 경과 : 도 3b와 같이 55일 치료로 완치됨.(4) Course: Completed with 55 days treatment as in FIG. 3b.

도 1 내지 도 3은 본 발명의 일실시예에 따른 무좀 치료 조성물을 이용하여 환자에게 치료를 행한 임상 전후의 사진이다.1 to 3 are photographs before and after the clinical treatment for the patient using the athlete's foot treatment composition according to an embodiment of the present invention.

Claims (4)

지유, 까마중, 생지황을 발효하여 분쇄한 발효물로서, 지유 발효물 40-80 중량부, 까마중 발효물 10~40 중량부, 생지황 발효물 10~40 중량부;Fermented products obtained by fermenting the fat and fat of brown milk, black horse, raw sulfur, 40-80 parts by weight of fat milk fermented product, 10-40 parts by weight of fermented milk, 10-40 parts by weight of fresh sulfur fermented product; 마치현을 태운 잔재 10~30 중량부;10-30 parts by weight of residue burned Machi; 도꼬마리 3~10 중량부, 찔레나무뿌리 3~10 중량부, 백선피 3~10 중량부, 용담 3~10 중량부, 고삼 3~10 중량부를 물과 함께 용기에 넣고 다려 추출한 액기스 3~50 중량부; 및3 ~ 10 parts by weight of Dokomari, 3 ~ 10 parts by weight of brier roots, 3 ~ 10 parts by weight of ringworm skin, 3 ~ 10 parts by weight of gentian, and 3 ~ 10 parts by weight of red ginseng in a container with water part; And 청미래덩굴잎을 분쇄한 분쇄물 10~30 중량부;를 포함하여 이루어진 무좀 치료 조성물.Athlete's foot treatment composition comprising; 10 ~ 30 parts by weight of crushed crushed blue vine leaves. 지유, 까마중, 생지황 중 적어도 하나 이상을 발효하여 분쇄한 발효물 10~160 중량부;10 to 160 parts by weight of fermented milled by fermenting at least one or more of the fat, brown yam, raw sulfur; 마치현을 태운 잔재 10~30 중량부;10-30 parts by weight of residue burned Machi; 도꼬마리, 찔레나무뿌리, 백선피, 용담, 고삼 중 적어도 하나 이상을 물과 함께 용기에 넣고 다려 추출한 액기스 3~50 중량부; 및3 to 50 parts by weight of extract extracted by putting at least one or more of dokomari, brier roots, ringworm skin, gentian, red ginseng with water; And 청미래덩굴잎을 분쇄한 분쇄물 10~30 중량부;를 포함하여 이루어진 무좀 치료 조성물.Athlete's foot treatment composition comprising; 10 ~ 30 parts by weight of crushed crushed blue vine leaves. 지유, 까마중, 생지황 중 적어도 하나 이상을 발효하여 분쇄한 발효물; 마치현을 태운 잔재; 도꼬마리, 찔레나무뿌리, 백선피, 용담, 고삼 중 적어도 하나 이상을 물과 함께 용기에 넣고 다려 추출한 액기스; 및 청미래덩굴잎을 분쇄한 분쇄물;을 포함하여 이루어진 무좀 치료 조성물.Fermented products obtained by fermenting at least one or more of fat milk, black sea buckwheat and raw sulfur; Remnants burning Machi Prefecture; An extract obtained by putting iron at least one or more of oxtail, brier root, ringworm skin, gentian and red ginseng into a container with water and extracting it; Athlete's foot treatment composition comprising a; 지유 40 중량부, 까마중 20 중량부, 마치현 10 중량부, 생지황 10 중량부를 발효하여 분쇄한 발효물을 포함하여 이루어진 무좀 치료 조성물.Athlete's foot therapeutic composition comprising 40 parts by weight of fat milk, 20 parts by weight of yam, 10 parts by weight of machi Prefecture, 10 parts by weight of raw sulfur and fermented and ground.
KR1020090053823A 2009-06-17 2009-06-17 Athlete's foot therapeutic composition KR101052321B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020090053823A KR101052321B1 (en) 2009-06-17 2009-06-17 Athlete's foot therapeutic composition

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020090053823A KR101052321B1 (en) 2009-06-17 2009-06-17 Athlete's foot therapeutic composition

Publications (2)

Publication Number Publication Date
KR20100135452A KR20100135452A (en) 2010-12-27
KR101052321B1 true KR101052321B1 (en) 2011-07-27

Family

ID=43509892

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020090053823A KR101052321B1 (en) 2009-06-17 2009-06-17 Athlete's foot therapeutic composition

Country Status (1)

Country Link
KR (1) KR101052321B1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20220047426A (en) 2020-10-08 2022-04-18 김순식 Composition for treating athlete's foot and method for preparing composition for treating athlete's foot
KR20230114445A (en) 2022-01-25 2023-08-01 이지영 Composition for preventing and improving athlete's foot

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102697903A (en) * 2012-05-11 2012-10-03 贾晋科 Medicine for treating herpes zoster
CN102961482A (en) * 2012-11-30 2013-03-13 黄龙干 Medicine for treating tinea unguium and preparation method for same
CN104173622A (en) * 2014-09-02 2014-12-03 张坚斌 Foot bath powder for treating dermatophytosis
CN104707068A (en) * 2015-03-16 2015-06-17 广西金秀瑶族自治县亿草丰茂瑶药有限公司 Bath medicine as well as preparation method and application thereof
CN109316552A (en) * 2018-11-30 2019-02-12 无锡福祈制药有限公司 A kind of pharmaceutical composition for treating tinea pedis

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002226386A (en) 2001-01-30 2002-08-14 Rohto Pharmaceut Co Ltd Composition for integument containing plant extract
KR20030055154A (en) * 2001-12-24 2003-07-02 주식회사 하니로 A composition for treating a dermatitis and a method of preparing the same
KR20070032410A (en) * 2005-09-16 2007-03-22 노시웅 Compound for dermatrophytosis antibiosis and deodorization using natural extract
KR100717420B1 (en) 2006-08-28 2007-05-11 주식회사 한빛코리아 A healing composition able to treat allergy and athlete's foot

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002226386A (en) 2001-01-30 2002-08-14 Rohto Pharmaceut Co Ltd Composition for integument containing plant extract
KR20030055154A (en) * 2001-12-24 2003-07-02 주식회사 하니로 A composition for treating a dermatitis and a method of preparing the same
KR20070032410A (en) * 2005-09-16 2007-03-22 노시웅 Compound for dermatrophytosis antibiosis and deodorization using natural extract
KR100717420B1 (en) 2006-08-28 2007-05-11 주식회사 한빛코리아 A healing composition able to treat allergy and athlete's foot

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20220047426A (en) 2020-10-08 2022-04-18 김순식 Composition for treating athlete's foot and method for preparing composition for treating athlete's foot
KR20230114445A (en) 2022-01-25 2023-08-01 이지영 Composition for preventing and improving athlete's foot

Also Published As

Publication number Publication date
KR20100135452A (en) 2010-12-27

Similar Documents

Publication Publication Date Title
DeFilipps et al. The medicinal plants of Myanmar
KR101805004B1 (en) Fermentation method using medicinal leaf and skin external composition containing fermented extract by the method
Chandler et al. Herbal remedies of the Maritime Indians
KR101868050B1 (en) Fermentation method using medicinal flower and skin external composition containing fermented extract by the method
Qasem Prospects of wild medicinal and industrial plants of saline habitats in the Jordan valley
KR101052321B1 (en) Athlete&#39;s foot therapeutic composition
Uzodimma Medico-Ethnobotanical inventory of Ogii, Okigwe Imo State, South Eastern Nigeria-I
Hutchens A Handbook of Native American Herbs: The Pocket Guide to 125 Medicinal Plants and Their Uses
Khan et al. Medicinal plants of Sewa river catchment area in the Northwest Himalaya and its implication for conservation
Jana et al. Herbal Treatment To Skin Diseases: A Global Approach.
KR101052322B1 (en) Method of preparing athlete&#39;s foot treatment composition
CN104474028B (en) Ointment for the treatment of skin pruritus and preparation method thereof
Mariyam Roqaiya et al. A review on traditional uses and phytochemical properties of Mimusops elengi Linn.
Ariharan et al. Mahavilva-a sacred tree with immense medicinal secrets: a mini review
Upreti et al. Ethnolichenological studies in India: future prospects
Rahmatullah et al. A survey on medicinal plants used by the folk medicinal practitioners in three villages of Panchagarh and Thakurgaon district, Bangladesh
Tarantul et al. Dill (lat. Anéthum)
CN111840416A (en) Marrow-washing bone-setting liquid
Chillemi The complete guide to natural healing: a natural approach to healing the body and maintaining optimal health using herbal supplements, vitamins, minerals, fruits, vegetables and alternative medicine
Salgar et al. Contribution of poisonous plants in herbal remedies
Memon et al. Common folk medicinal and ethnomedicinal uses of thirty medicinal plants of districts Dadu and Jamshoro, Sindh, Pakistan
Subramaniam A survey of medicinal plants from Chitheri hills in Dharmapuri district, Tamilnadu
CN111686165A (en) Pure traditional Chinese medicine composition for relieving itching of private parts, preparation and application of pure traditional Chinese medicine composition in cleaning private parts
Rani et al. Ethnomedicinal, Pharmacological and Phytochemical Screening of Supari (Areca catechu Linn.): A Review
Ilandara et al. Phytochemical and ethno-pharmacological properties of Desmodium triflorum; A Review

Legal Events

Date Code Title Description
A201 Request for examination
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20140721

Year of fee payment: 4

FPAY Annual fee payment

Payment date: 20150702

Year of fee payment: 5

FPAY Annual fee payment

Payment date: 20160718

Year of fee payment: 6

FPAY Annual fee payment

Payment date: 20170921

Year of fee payment: 7

R401 Registration of restoration
R401 Registration of restoration